{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:36:32Z","timestamp":1792672592714,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["561\/11"],"award-info":[{"award-number":["561\/11"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"EC | European Research Council","doi-asserted-by":"publisher","award":["309377"],"award-info":[{"award-number":["309377"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease affecting both the upper and lower motor neurons (MNs), with no effective treatment currently available. Early pathological events in ALS include perturbations in axonal transport (AT), formation of toxic protein aggregates and Neuromuscular Junction (NMJ) disruption, which all lead to axonal degeneration and motor neuron death. Pridopidine is a small molecule that has been clinically developed for Huntington disease. Here we tested the efficacy of pridopidine for ALS using in vitro and in vivo models. Pridopidine beneficially modulates AT deficits and diminishes NMJ disruption, as well as motor neuron death in SOD1<jats:sup>G93A<\/jats:sup> MNs and in neuromuscular co-cultures. Furthermore, we demonstrate that pridopidine activates the ERK pathway and mediates its beneficial effects through the sigma-1 receptor (S1R). Strikingly, in vivo evaluation of pridopidine in SOD1<jats:sup>G93A<\/jats:sup> mice reveals a profound reduction in mutant SOD1 aggregation in the spinal cord, and attenuation of NMJ disruption, as well as subsequent muscle wasting. Taken together, we demonstrate for the first time that pridopidine improves several cellular and histological hallmark pathologies of ALS through the S1R.<\/jats:p>","DOI":"10.1038\/s41419-019-1451-2","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T14:05:15Z","timestamp":1551449115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model"],"prefix":"10.1038","volume":"10","author":[{"given":"Ariel","family":"Ionescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Gradus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Topaz","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Maimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noi","family":"Saraf Avraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Geva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Perlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"1451_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnins.2014.00252","volume":"8","author":"EB Moloney","year":"2014","unstructured":"Moloney, E. B., de Winter, F. & Verhaagen, J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 8, 252 (2014).","journal-title":"Front. Neurosci."},{"key":"1451_CR2","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 185, 232\u2013240 (2004).","journal-title":"Exp. Neurol."},{"key":"1451_CR3","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3390\/ijms13011225","volume":"13","author":"K Ikenaka","year":"2012","unstructured":"Ikenaka, K. et al. Disruption of axonal transport in motor neuron diseases. Int. J. Mol. Sci. 13, 1225\u20131238 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"1451_CR4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00401-013-1125-6","volume":"125","author":"AM Blokhuis","year":"2013","unstructured":"Blokhuis, A. M., Groen, E. J. N., Koppers, M., van den Berg, L. H. & Pasterkamp, R. J. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 777\u2013794 (2013).","journal-title":"Acta Neuropathol."},{"key":"1451_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362 (1993).","journal-title":"Nature"},{"key":"1451_CR6","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.8209258","volume":"264","author":"ME Gurney","year":"1994","unstructured":"Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772\u20131775 (1994).","journal-title":"Science"},{"key":"1451_CR7","first-page":"808","volume":"300","author":"M Hafezparast","year":"2003","unstructured":"Hafezparast, M. et al. Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde. Transp. Sci. 300, 808\u2013812 (2003).","journal-title":"Transp. Sci."},{"key":"1451_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/brain\/awx370","volume":"141","author":"D Brenner","year":"2018","unstructured":"Brenner, D. et al. Hot-spot KIF5A mutations cause familial ALS. Brain 141, 688\u2013697 (2018).","journal-title":"Brain"},{"key":"1451_CR9","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","volume":"232","author":"K Sahlholm","year":"2015","unstructured":"Sahlholm, K. et al. Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses. Psychopharmacology 232, 3443\u20133453 (2015).","journal-title":"Psychopharmacology"},{"key":"1451_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2016.10.006","volume":"97","author":"D Ryskamp","year":"2017","unstructured":"Ryskamp, D. et al. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol. Dis. 97, 46\u201359 (2017).","journal-title":"Neurobiol. Dis."},{"key":"1451_CR11","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.1093\/hmg\/ddw238","volume":"25","author":"M Geva","year":"2016","unstructured":"Geva, M. et al. Pridopidine activates neuroprotective pathways impaired in Huntington disease. Hum. Mol. Genet. 25, 3975\u20133987 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1451_CR12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi, T. & Su, T.-P. Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca2\u2009+\u2009signaling and cell survival. Cell 131, 596\u2013610 (2007).","journal-title":"Cell"},{"key":"1451_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2017.08.007","volume":"59","author":"J Hong","year":"2017","unstructured":"Hong, J., Wang, L., Zhang, T., Zhang, B. & Chen, L. Sigma-1 receptor knockout increases \u03b1-synuclein aggregation and phosphorylation with loss of dopaminergic neurons in substantia nigra. Neurobiol. Aging 59, 171\u2013183 (2017).","journal-title":"Neurobiol. Aging"},{"key":"1451_CR14","doi-asserted-by":"publisher","first-page":"e76941","DOI":"10.1371\/journal.pone.0076941","volume":"8","author":"T Mori","year":"2013","unstructured":"Mori, T., Hayashi, T., Hayashi, E. & Su, T.-P. Sigma-1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS. One. 8, e76941 (2013).","journal-title":"PLoS. One."},{"key":"1451_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/jpet.109.160960","volume":"332","author":"J Meunier","year":"2010","unstructured":"Meunier, J. & Hayashi, T. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor B. J. Pharmacol. Exp. Ther. 332, 388\u2013397 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1451_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2010.02.022","volume":"167","author":"TA Mavlyutov","year":"2010","unstructured":"Mavlyutov, T. A., Epstein, M. L., Andersen, K. A., Ziskind-Conhaim, L. & Ruoho, A. E. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167, 247\u2013255 (2010).","journal-title":"Neuroscience"},{"key":"1451_CR17","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1523\/JNEUROSCI.06-06-01757.1986","volume":"6","author":"AL Gundlach","year":"1986","unstructured":"Gundlach, A. L., Largent, B. L. & Snyder, S. H. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (\u2009+\u2009)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J. Neurosci. 6, 1757\u20131770 (1986).","journal-title":"J. Neurosci."},{"key":"1451_CR18","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1046\/j.1460-9568.2003.02950.x","volume":"18","author":"F Langa","year":"2003","unstructured":"Langa, F. et al. Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. Eur. J. Neurosci. 18, 2188\u20132196 (2003).","journal-title":"Eur. J. Neurosci."},{"key":"1451_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/brain\/awv008","volume":"138","author":"N Bernard-Marissal","year":"2015","unstructured":"Bernard-Marissal, N., M\u00e9dard, J.-J., Azzedine, H. & Chrast, R. Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. Brain 138, 875\u2013890 (2015).","journal-title":"Brain"},{"key":"1451_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2013.02.035","volume":"240","author":"TA Mavlyutov","year":"2013","unstructured":"Mavlyutov, T. A. et al. Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 240, 129\u2013134 (2013).","journal-title":"Neuroscience"},{"key":"1451_CR21","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ana.22534","volume":"70","author":"A Al-Saif","year":"2011","unstructured":"Al-Saif, A., Al-Mohanna, F. & Bohlega, S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70, 913\u2013919 (2011).","journal-title":"Ann. Neurol."},{"key":"1451_CR22","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.15252\/emmm.201606403","volume":"8","author":"S Watanabe","year":"2016","unstructured":"Watanabe, S. et al. Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 8, 1421\u20131437 (2016).","journal-title":"EMBO Mol. Med."},{"key":"1451_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.22274","volume":"68","author":"AA Luty","year":"2010","unstructured":"Luty, A. A. et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann. Neurol. 68, 639\u2013649 (2010).","journal-title":"Ann. Neurol."},{"key":"1451_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1242\/jcs.167544","volume":"128","author":"EE Zahavi","year":"2015","unstructured":"Zahavi, E. E. et al. A compartmentalized microfluidic neuromuscular co-culture system reveals spatial aspects of GDNF functions. J. Cell. Sci. 128, 1241\u20131252 (2015).","journal-title":"J. Cell. Sci."},{"key":"1451_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejcb.2015.11.004","volume":"95","author":"A Ionescu","year":"2016","unstructured":"Ionescu, A., Zahavi, E. E., Gradus, T., Ben-Yaakov, K. & Perlson, E. Compartmental microfluidic system for studying muscle-neuron communication and neuromuscular junction maintenance. Eur. J. Cell Biol. 95, 69\u201388 (2016).","journal-title":"Eur. J. Cell Biol."},{"key":"1451_CR26","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.1073\/pnas.1006869107","volume":"107","author":"LG Bilsland","year":"2010","unstructured":"Bilsland, L. G. et al. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl Acad. Sci. USA 107, 20523\u201320528 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1451_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrn3380","volume":"14","author":"S Millecamps","year":"2013","unstructured":"Millecamps, S. & Julien, J.-P. Axonal transport deficits and neurodegenerative diseases. Nat. Rev. Neurosci. 14, 161\u2013176 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"1451_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neulet.2009.02.061","volume":"454","author":"A Stevenson","year":"2009","unstructured":"Stevenson, A. et al. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci. Lett. 454, 161\u2013164 (2009).","journal-title":"Neurosci. Lett."},{"key":"1451_CR29","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","volume":"286","author":"A Bonni","year":"1999","unstructured":"Bonni, A. et al. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358\u20131362 (1999).","journal-title":"Science"},{"key":"1451_CR30","doi-asserted-by":"crossref","unstructured":"Zahavi, E. E. et al. The receptor tyrosin kinase TrkB signals without dimerization at the plasma membrane. Sci. Signal. 11, eaao4006 (2018).","DOI":"10.1126\/scisignal.aao4006"},{"key":"1451_CR31","doi-asserted-by":"publisher","first-page":"e75760","DOI":"10.1371\/journal.pone.0075760","volume":"8","author":"Y Kimura","year":"2013","unstructured":"Kimura, Y., Fujita, Y., Shibata, K., Mori, M. & Yamashita, T. Sigma-1 receptor enhances neurite elongation of cerebellar granule neurons via TrkB signaling. PLoS ONE 8, e75760 (2013).","journal-title":"PLoS ONE"},{"key":"1451_CR32","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1021\/bi100922r","volume":"49","author":"P Hammarstro\u0308m","year":"2010","unstructured":"Hammarstro\u0308m, P. et al. A Fluorescent pentameric thiophene derivative detects in vitro-formed prefibrillar protein aggregates. Biochemistry 49, 6838\u20136845 (2010).","journal-title":"Biochemistry"},{"key":"1451_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","volume":"559","author":"Y Ono","year":"2014","unstructured":"Ono, Y. et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci. Lett. 559, 174\u2013178 (2014).","journal-title":"Neurosci. Lett."},{"key":"1451_CR34","doi-asserted-by":"crossref","unstructured":"Maimon, R. et al. miR126-5p down-regulation facilitates axon degeneration and NMJ disruption via a non-cell-autonomous mechanism in ALS. J. Neurosci. 38, 5478\u20135494 (2018).","DOI":"10.1523\/JNEUROSCI.3037-17.2018"},{"key":"1451_CR35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1089\/neu.2010.1674","volume":"28","author":"C Penas","year":"2011","unstructured":"Penas, C. et al. Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury. J. Neurotrauma 28, 831\u2013840 (2011).","journal-title":"J. Neurotrauma"},{"key":"1451_CR36","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/syn.21549","volume":"66","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto, M., Hayashi, T., Urfer, R., Mita, S. & Su, T.-P. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor. Synapse 66, 630\u2013639 (2012).","journal-title":"Synapse"},{"key":"1451_CR37","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1111\/bph.13076","volume":"172","author":"M Malik","year":"2015","unstructured":"Malik, M. et al. The effects of sigma (\u03c31) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice. Br. J. Pharmacol. 172, 2519\u20132531 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"1451_CR38","doi-asserted-by":"publisher","first-page":"ddw105","DOI":"10.1093\/hmg\/ddw105","volume":"25","author":"KR Baldwin","year":"2016","unstructured":"Baldwin, K. R., Godena, V. K., Hewitt, V. L. & Whitworth, A. J. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum. Mol. Genet. 25, ddw105 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"1451_CR39","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuron.2005.01.023","volume":"45","author":"E Perlson","year":"2005","unstructured":"Perlson, E. et al. Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve. Neuron 45, 715\u2013726 (2005).","journal-title":"Neuron"},{"key":"1451_CR40","doi-asserted-by":"publisher","first-page":"6742","DOI":"10.1073\/pnas.1422001112","volume":"112","author":"SYA Tsai","year":"2015","unstructured":"Tsai, S.-Y. A., Pokrass, M. J., Klauer, N. R., Nohara, H. & Su, T.-P. Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid. Proc. Natl Acad. Sci. USA 112, 6742\u20136747 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1451_CR41","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1073\/pnas.1504081112","volume":"112","author":"H Kadavath","year":"2015","unstructured":"Kadavath, H. et al. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers. Proc. Natl Acad. Sci. 112, 7501\u20137506 (2015).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1451_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier, L. R. et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118, 127\u2013138 (2004).","journal-title":"Cell"},{"key":"1451_CR43","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1101\/gad.1640108","volume":"22","author":"H Nishitoh","year":"2008","unstructured":"Nishitoh, H. et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22, 1451\u20131464 (2008).","journal-title":"Genes Dev."},{"key":"1451_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fncel.2015.00225","volume":"9","author":"SS Leal","year":"2015","unstructured":"Leal, S. S. & Gomes, C. M. Calcium dysregulation links ALS defective proteins and motor neuron selective vulnerability. Front. Cell. Neurosci. 9, 225 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"1451_CR45","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"SC Barber","year":"2006","unstructured":"Barber, S. C., Mead, R. J. & Shaw, P. J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim Biophys. Acta - Mol. Basis Dis. 1762, 1051\u20131067 (2006).","journal-title":"Biochim Biophys. Acta - Mol. Basis Dis."},{"key":"1451_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1083\/jcb.140.4.911","volume":"140","author":"SX Bamji","year":"1998","unstructured":"Bamji, S. X. et al. Thep75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell. Biol. 140, 911\u2013923 (1998).","journal-title":"J. Cell. Biol."},{"key":"1451_CR47","doi-asserted-by":"publisher","first-page":"9903","DOI":"10.1523\/JNEUROSCI.0813-09.2009","volume":"29","author":"E Perlson","year":"2009","unstructured":"Perlson, E. et al. A switch in retrograde signaling from survival to stress in rapid-onset neurodegeneration. J. Neurosci. 29, 9903\u20139917 (2009).","journal-title":"J. Neurosci."},{"key":"1451_CR48","doi-asserted-by":"publisher","first-page":"10614","DOI":"10.1074\/jbc.M106116200","volume":"277","author":"CY Wang","year":"2002","unstructured":"Wang, C. Y. et al. Regulation of neuromuscular synapse development by glial cell line-derived neurotrophic factor and neurturin. J. Biol. Chem. 277, 10614\u201310625 (2002).","journal-title":"J. Biol. Chem."},{"key":"1451_CR49","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1523\/JNEUROSCI.21-16-06136.2001","volume":"21","author":"CR Keller-Peck","year":"2001","unstructured":"Keller-Peck, C. R. et al. Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J. Neurosci. 21, 6136\u20136146 (2001).","journal-title":"J. Neurosci."},{"key":"1451_CR50","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","volume":"22","author":"LJ Wang","year":"2002","unstructured":"Wang, L.-J. et al. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22, 6920\u20136928 (2002).","journal-title":"J. Neurosci."},{"key":"1451_CR51","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1093\/hmg\/ddm226","volume":"16","author":"KJ De Vos","year":"2007","unstructured":"De Vos, K. J. et al. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16, 2720\u20132728 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"1451_CR52","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1242\/jcs.01130","volume":"117","author":"KE Miller","year":"2004","unstructured":"Miller, K. E. & Sheetz, M. P. Axonal mitochondrial transport and potential are correlated. J. Cell. Sci. 117, 2791\u20132804 (2004).","journal-title":"J. Cell. Sci."},{"key":"1451_CR53","doi-asserted-by":"publisher","first-page":"eaao4006","DOI":"10.1126\/scisignal.aao4006","volume":"11","author":"EE Zahavi","year":"2018","unstructured":"Zahavi, E. E. et al. The receptor tyrosine kinase TrkB signals without dimerization at the plasma membrane. Sci. Signal. 11, eaao4006 (2018).","journal-title":"Sci. Signal."},{"key":"1451_CR54","doi-asserted-by":"publisher","first-page":"e2414","DOI":"10.1038\/cddis.2016.319","volume":"7","author":"M Ka","year":"2016","unstructured":"Ka, M., Kook, Y.-H., Liao, K., Buch, S. & Kim, W.-Y. Transactivation of TrkB by Sigma-1 receptor mediates cocaine-induced changes in dendritic spine density and morphology in hippocampal and cortical neurons. Cell Death Dis. 7, e2414\u2013e2414 (2016).","journal-title":"Cell Death Dis."},{"key":"1451_CR55","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IRA Mackenzie","year":"2007","unstructured":"Mackenzie, I. R. A. et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis withSOD1 mutations. Ann. Neurol. 61, 427\u2013434 (2007).","journal-title":"Ann. Neurol."},{"key":"1451_CR56","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10\u2013S17 (2004).","journal-title":"Nat. Med."},{"key":"1451_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/bs.mcb.2015.06.016","volume":"13","author":"S Gluska","year":"2016","unstructured":"Gluska, S., Chein, M., Rotem, N., Ionescu, A. & Perlson, E. Tracking Quantum-Dot labeled neurotropic factors transport along primary neuronal axons in compartmental microfluidic chambers. Methods Cell Biol. 13, 365\u2013387 (2016).","journal-title":"Methods Cell Biol."},{"key":"1451_CR58","doi-asserted-by":"publisher","first-page":"e1004348","DOI":"10.1371\/journal.ppat.1004348","volume":"10","author":"S Gluska","year":"2014","unstructured":"Gluska, S. et al. Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathog. 10, e1004348 (2014).","journal-title":"PLoS Pathog."},{"key":"1451_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep44500","volume":"7","author":"N Rotem","year":"2017","unstructured":"Rotem, N. et al. ALS along the axons \u2013 expression of coding and noncoding RNA differs in axons of ALS models. Sci. Rep. 7, 44500 (2017).","journal-title":"Sci. Rep."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1451-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1451-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:38:00Z","timestamp":1671208680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1451-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["1451"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1451-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"assertion":[{"value":"30 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project was funded by Teva Pharmaceuticals Ltd (Netanya Israel), which owns patent rights for pridopidine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"210"}}